Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
Mentions
2 mentions · latest on 22 Aug 2026
| The No Pile | - | 22 Aug 2026 | |
| Value Hive PodcastPodcast | Peter Mantas: The Biotech Bubble Whisperer | - | 19 Jun 2026 |